Fjarde Ap-fonden’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.25M | Buy |
|
|||||
|
2025
Q2 | $5.29M | Buy |
|
|||||
|
2025
Q1 | $5.77M | Buy |
|
|||||
|
2024
Q4 | $5.08M | Buy |
|
|||||
|
2024
Q3 | $5.14M | Buy |
|
|||||
|
2024
Q1 | $5.51M | Buy |
|
|||||
|
2023
Q4 | $5.86M | Sell |
|
|||||
|
2023
Q3 | $6.39M | Buy |
|
|||||
|
2023
Q2 | $5.79M | Buy |
|
|||||
|
2023
Q1 | $6.41M | Buy |
|
|||||
|
2022
Q4 | $6.64M | Sell |
|
|||||
|
2022
Q3 | $6.45M | Hold |
|
|||||
|
2022
Q2 | $6.45M | Buy |
|
|||||
|
2022
Q1 | $5.04M | Sell |
|
|||||
|
2021
Q4 | $5.85M | Sell |
|
|||||
|
2021
Q3 | $5.33M | Sell |
|
|||||
|
2021
Q2 | $5.94M | Sell |
|
|||||
|
2021
Q1 | $5.81M | Buy |
|
|||||
|
2020
Q4 | $6.57M | Sell |
|
|||||
|
2020
Q3 | $5.81M | Buy |
|
|||||
|
2020
Q2 | $8.74M | Buy |
|
|||||
|
2020
Q1 | $5.62M | Buy |
|
|||||
|
2019
Q4 | $5.1M | Buy |
|
|||||
|
2019
Q3 | $3.51M | Buy |
|
|||||
|
2019
Q2 | $3.64M | Sell |
|
|||||
|
2019
Q1 | $4.96M | Buy |
|
|||||
|
2018
Q4 | $3.92M | Sell |
|
|||||
|
2018
Q3 | $5.46M | Sell |
|
|||||
|
2018
Q2 | $5.39M | Buy |
|
|||||
|
2018
Q1 | $4.43M | Sell |
|
|||||
|
2017
Q4 | $5.05M | Buy |
|
|||||
|
2017
Q3 | $4.55M | Sell |
|
|||||
|
2017
Q2 | $4.52M | Buy |
|
|||||
|
2017
Q1 | $3.85M | Sell |
|
|||||
|
2016
Q4 | $3.89M | Sell |
|
|||||
|
2016
Q3 | $4.49M | Buy |
|
|||||
|
2016
Q2 | $3.73M | Sell |
|
|||||
|
2016
Q1 | $4.1M | Buy |
|
|||||
|
2015
Q4 | $4.76M | Buy |
|
|||||
|
2015
Q3 | $4.65M | Sell |
|
|||||
|
2015
Q2 | $6.12M | Sell |
|
|||||
|
2015
Q1 | $5.77M | Hold |
|
|||||
|
2014
Q4 | $4.19M | Hold |
|
|||||
|
2014
Q3 | $3.34M | Sell |
|
|||||
|
2014
Q2 | $3.12M | Hold |
|
|||||
|
2014
Q1 | $3.42M | Buy |
|
|||||
|
2013
Q4 | $3.42M | Sell |
|
|||||
|
2013
Q3 | $3.65M | Buy |
|
|||||
|
2013
Q2 | $2.69M | Buy |
|